CClinicalTrials.gg
Sign In
CompletedNCT05296187Updated Apr 9, 2026

Efficacy of TEAS On Prevention of Propofol Injection Pain in Children

An interventional study of TEAS in Injection Site, sponsored by Konya Meram State Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by Konya Meram State Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Years to 13 Years
Sex
All
01

Study summary

The purpose of this study is to determine the efficacy of transcutaneous electrical acupoint stimulation for the prevention of propofol injection pain in children.

Read the detailed description

Pain from the injection of propofol is a common side effect during anesthetic practice. Various methods have been used to reduce this pain. This prospective, randomized study was designed to determine the efficacy of transcutaneous electrical acupuncture point stimulation in reducing propofol injection pain in children.

02

Conditions studied

  • Injection Site
03

In context

Lead sponsor

Konya Meram State Hospital is the lead sponsor of 45 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • ASA I-II and aged 6-13 years patents who will undergo elective surgery under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • patients with propofol allergy
  • patients who have renal, hepatic, cardiac, neurological, psychiatric disease
  • Cardiac and cranial surgery
  • Pacemaker,
  • Emergency surgery and patients requiring rapid serial induction
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    GROUP TEAS

    Patients will receive TEAS bilaterally at two acupoints: Hegu (L14) and Neiguan (PC6).

    Device: TEAS

  • Placebo comparator
    Control Sham Group

    Patients in the sham group will be undergoing electrode attachment on the target acupoints without electronic stimulation.

    Device: TEAS

Interventions

  • DeviceTEAS

    Transcutaneous electrical acupuncture stimulation

06

What researchers measure

Primary outcomes

  1. Pain with propofol injection

    pain will be assessed using a four point behavioral scale: 1= no pain (no reaction); 2= mild pain (grimace); 3= moderate pain (grimace+cry); 4= severe pain (cry+withdrawal)

    Time frame: 5 minutes

07

Study locations

1 site
  • Betul Kozanhan
    Konya, 42005, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05296187
Lead sponsor
Konya Meram State Hospital
Responsible party
Betul Kozanhan (Ass.Prof., Konya Meram State Hospital) — Principal investigator
First posted
Mar 25, 2022
Start date
Feb 14, 2025
Primary completion
Aug 26, 2025
Completion
Aug 26, 2025
Last update
Apr 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Konya Meram State Hospital

Start the discussion